SpyGlass Pharma, Inc.
SpyGlass Pharma, Inc. scores highest on Torque (77) and lowest on Price (19). Its PosiPenta is 48.43 out of 100, around the middle of similar companies.
On the Penta Grid this week, SpyGlass Pharma, Inc. is Grid #308 of 837 in the Healthcare sector in United States, and Grid #2,063 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| SpyGlass Pharma, Inc. | 48.43 | 19 | 23 | 72 | 77 | 51 |
| Integra LifeSciences Holdings Corporation | 58.12 | 40 | 87 | 65 | 42 | 57 |
| Jade Biosciences, Inc. | 44.78 | 30 | 23 | 50 | 80 | 41 |
| Monte Rosa Therapeutics, Inc. | 36.56 | 31 | 28 | 31 | 53 | 39 |
| SI-BONE, Inc. | 52.21 | 14 | 45 | 90 | 56 | 56 |
| ArriVent BioPharma, Inc. | 39.97 | 26 | 20 | 46 | 65 | 43 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -9.56 |
| P/B ratio | 3.45 |
EEarnings
| Trailing EPS | ₹-237.73 |
| Forward EPS | ₹-266.57 |
NNitro
| Price | 2273.16 |
| 52-week high | 3072.55 |
| 52-week low | 1615.84 |
| Fall from 52-week high | 26.0% |
TTorque
| Return on equity (ROE) | — |
| Debt-to-equity | 0.01 |
AAnchor
| Beta (price swings) | — |
| Market cap | ₹7,603 Cr |
| Insider holding | 4.28% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is SpyGlass Pharma, Inc.'s PosiPenta score?
SpyGlass Pharma, Inc.'s PosiPenta is 48.43 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does SpyGlass Pharma, Inc. stand on the Penta Grid?
On the Penta Grid this week, SpyGlass Pharma, Inc. is Grid #308 of 837 in the Healthcare sector in United States, and Grid #2,063 of 4,000 in United States.
Which PosiPenta pillar is strongest for SpyGlass Pharma, Inc.?
Torque (durability), with a score of 77 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for SpyGlass Pharma, Inc.?
Price (valuation), with a score of 19 out of 100: much weaker than most similar companies.
Has SpyGlass Pharma, Inc.'s PosiPenta changed since last week?
Yes, it rose 1.70 points, from 46.73 to 48.43.
PositoAI is for research and education only and is not investment advice.